{
    "Title": "Assessment of Inhibitors of Pathogenic Crimean-Congo Hemorrhagic Fever Virus Strains Using Virus-Like Particles",
    "URL": "https://doi.org/10.1371/journal.pntd.0004259",
    "Published": "December 1, 2015",
    "Subject_Areas": [
        "Transfection",
        "Glycoproteins",
        "Cell signaling",
        "Crimean-Congo hemorrhagic fever",
        "Plasmid construction",
        "Signal inhibition",
        "Viral entry",
        "Genomics"
    ],
    "Authors": {
        "Marko Zivcec": [
            "Viral Special Pathogens Branch, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America"
        ],
        "Maureen G. Metcalfe": [
            "Infectious Disease Pathology Branch, Division of High Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America"
        ],
        "César G. Albariño": [
            "Viral Special Pathogens Branch, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America"
        ],
        "Lisa W. Guerrero": [
            "Viral Special Pathogens Branch, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America"
        ],
        "Scott D. Pegan": [
            "Department of Pharmaceutical and Biomedical Sciences, University of Georgia, Athens, Georgia, United States of America"
        ],
        "Christina F. Spiropoulou": [
            "Viral Special Pathogens Branch, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America"
        ],
        "Éric Bergeron": [
            "Viral Special Pathogens Branch, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America"
        ]
    }
}